Related Experiment Video

Updated: Aug 1, 2026

Analysis of Cell Cycle Position in Mammalian Cells
12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta

I Reynisdóttir1, K Polyak, A Iavarone

  • 1Cell Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

Genes & Development
|August 1, 1995
PubMed

Insights

Transforming growth factor-beta (TGF-beta) triggers cell cycle arrest by increasing specific inhibitors (p15Ink4B and p21Cip1) that block cyclin-dependent kinases (Cdks) in epithelial cells.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Cell cycle progression relies on cyclin D-dependent kinases (Cdks) Cdk4/Cdk6 and Cdk2.
  • The Cdk inhibitor p27Kip1 is abundant in proliferating cells, complexed with Cdks.

Purpose of the Study:

  • To investigate the mechanism by which transforming growth factor-beta (TGF-beta) induces G1 cell cycle arrest in epithelial cells.
  • To elucidate the roles of Cdk inhibitors p15Ink4B and p21Cip1 in TGF-beta-mediated cell cycle regulation.

Main Methods:

  • Analysis of Cdk inhibitor expression and Cdk-inhibitor complex formation in response to TGF-beta.
  • In vitro inhibition assays using recombinant p15.
  • In vivo studies involving p15 overexpression.

Main Results:

  • TGF-beta elevates p15Ink4B, causing p27Kip1 release from Cdk4/Cdk6 and subsequent binding to Cdk2.
  • In keratinocytes, TGF-beta also increases p21Cip1, leading to Cdk2 inhibition.
  • These events correlate with G1 cell cycle arrest without altering overall G1 Cdk levels.

Conclusions:

  • TGF-beta induces G1 arrest in epithelial cells through the combined action of Ink4 (p15) and Cip/Kip (p21, p27) Cdk inhibitors.
  • The study reveals a cooperative mechanism involving inhibitor exchange and direct inhibition of cyclin-Cdk complexes.
  • Downregulation of Cdk2 and Cdk4 follows cell cycle arrest, potentially indicating adaptation to quiescence.

More Related Videos

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...